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ABSTRACT 
Background Despite improvements in nutrition practice during the last decades, problems 
still exist in meeting estimated nutritional needs, especially for extremely preterm (EPT) 
infants. Today, it is still not known how optimal nutrition and growth will hold in the future. 
The objectives of this thesis were i) to investigate changes over time regarding nutrition 
practice in Stockholm and the associations on growth and morbidities such as 
bronchopulmonary dysplasia (BPD) and retinopathy of prematurity (ROP), and ii) to 
investigate perioperative nutrition surrounding ductal ligation for patent ductus arteriosus 
(PDA) of EPT infants born in Sweden. 
Methods This is a population based study of EPT infants born in Sweden before 27 
completed gestational weeks between 2004 and 2011 and who survived >24 h (n=489). 
Detailed nutritional data retrieved from hospital records including all fluid intakes supplied 
intravenously and enterally together with anthropometrical data were retrospectively 
registered in Nutrium, a nutrition calculating software. Comprehensive data on cohort 
characteristics, neonatal morbidity and mortality were obtained from the Extremely Preterm 
Infants in Sweden Study (EXPRESS) and the Swedish National Quality register. 
Results Nutritional intakes in Stockholm have increased continuously over time during 2004 
to 2011and growth improved significanly during later years compared to year-group 2004-
2005, (Paper I). The enteral feed advancement and time to full feeds during the year-group 
2008-2009 were faster compared to all other years. During the years 2010 to 2011, the 
proportion of parenteral nutrition was larger and median time to full feeds decreased 
compared to all other years. Initial growth restriction was reduced by higher energy and 
protein intake the first week and lower risk of BPD and ROP was associated with higher 
energy intake the first month, (Paper II). The estimated absolute risk of BPD and ROP 
decreased when energy intake on days 7 to 27 increased from 110 to 120 and 120 to 130 
kcal/kg/d. Reduced risk of BPD was associated with higher energy- and protein intake despite 
critical illness (>10 days mechanical ventilation), which was not the case in ROP. 
Perioperative nutrition surrounding ductal ligation for PDA is suboptimal in Sweden, (Paper 
III). Energy, protein and fat intake were not improved on the third day post-surgery compared 
to the third day prior surgery. Moreover, protein intake during postneonatal period (> 28 
days) was significantly lower in infants undergoing ductal ligation compared to those 
operated between days 7 and 27. Nutritional intakes between NICUs in Sweden differed, 
particularly regarding intakes of total, enteral and parenteral fluids, (Paper IV). On the day of 
ductal ligation, nutritional intakes at all NICUs were lower compared to the other 
perioperative days.  
Conclusions This thesis highlights the importance of neonatal nutrition. Increased nutritional 
intake during the first postnatal week and month are associated with reduced initial growth 
restriction and morbidity. We conclude that there is room for improvement regarding 
nutritional intakes and growth in general and surrounding perioperative week in particular. 
  
More research is needed to investigate the special nutritional needs of vulnerable, ill EPT 
infants. 
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1 BACKGROUND 
1.1 INCIDENCE OF PRETERM BIRTH 
The World Health Organisation’s (WHO) definition of preterm birth is birth before 37 
completed weeks of gestation (1). About 15 million infants (10 %) around the world are born 
preterm each year. There are great variations between regions and countries of which the 
Northern European countries have the lowest rate of premature birth (2). In 2016, the preterm 
birth rate in Sweden was 5.6 % (3). Preterm birth is divided into three sub-categories: 
moderate to late preterm (32 to <37 gestational weeks); very preterm (28 to <32 gestational 
weeks) and extremely preterm or extremely low gestational age (ELGA, <28 gestational 
weeks) (2). In the Extremely Preterm infants in Sweden Study (EXPRESS), infants born with 
a gestational age less than 27 completed weeks during a three-year period were included, 
entailing approximately 0.2 % of all new-borns in Sweden for that time period (4). The 
aetiology of preterm birth is mainly unknown. However, preterm labour and preterm rupture 
of membranes often cause preterm birth (5). Preeclampsia, placental haemorrhage, infection, 
multiple birth and intrauterine growth restriction are also mentioned as reasons for preterm 
delivery. Other risk factors are e.g., fertility problems, assisted conception, smoking, drug 
use, extreme under- or overweight. 
 
1.2 IMPROVEMENTS IN NEONATAL INTENSIVE CARE 
In Sweden, modern treatment of extremely preterm (EPT) infants based on physiological 
principles and technological improvements started between the years 1960 and 1970. This, 
together with increased centralisation of neonatal intensive care units (NICU), resulted in an 
increase of surviving infants and a decrease of viability limits (6). Improved survival during 
later years of the last century was at the cost of an increased number of infants with severe 
disability. A Swedish study published in 1997 showed that none of the infants born in 
gestational week 22 survived during the years 1990 and 1992 (7). A decade later, results from 
the EXPRESS cohort including infants born between 2004 and 2007, 51 infants below 23 
completed gestational weeks were live-born, of those five infants showed a one-year survival 
(4). Since infants born at the lower limit of viability require most resources at the NICU and 
many of them are affected of neurodevelopmental disability, there is concern that remaining 
resources are not sufficient to meet the follow-up needs of the fragile infant and their families 
(8). Great improvements in neonatal care have also been reported from England (EPICure 
study) comparing short term outcomes after extreme preterm birth in 1995 and 2006 (9, 10). 
As mortality rates and severe sequelae such as cerebral palsy have decreased (11), interest for 
nutritional management of preterm infants has increased.  
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1.3 NUTRITIONAL SUPPLY 
Between the years 1960 to 1970, nutritional treatment was only introduced when the 
premature infant was still alive after two or three days’ postnatal age (6). Major cumulative 
nutritional deficits and postnatal growth restriction during the first week of life have been 
demonstrated in several nutritional studies (12-15). Nutrition should be introduced as soon as 
possible after birth to prevent deficits that could be detrimental for the most vulnerable 
infants (16). Neonatal experts have agreed upon consensus guidelines regarding nutritional 
intakes of EPT infants (16-20). 
Before birth, the nutritional supply in utero is mediated through the umbilical cord from the 
mother’s placenta to the foetus. After birth, the nutritional intake is shifting to parenteral 
nutrition (PN) combined with minimal enteral feeding. Due to the risk for sepsis or PN 
related liver problems and the need for microbial colonisation of the sterile gut, PN should be 
substituted as soon as possible by enteral nutrition (EN) (21-24). However, in the preterm 
infant, limited tolerance to EN may be due to gastrointestinal tract immaturity leading to, 
impaired motility, digestion and absorption of nutrients (25). It is challenging in EPT infants 
to prevent nutritional deficits and to reach optimal growth due to the infants’ limited stores of 
nutrients at birth and the difficulties to supply optimal amounts of both energy and nutrients 
after birth (26).  
 
1.3.1 Parenteral nutrition 
PN is usually administrated through central venous catheters and is the main supply of 
nutrition during the first postnatal week. In a study of Skouroliakou et al, two types of total 
PN prescription methods in preterm infants were compared (27). The use of protocols 
prescribed by individual physicians resulted in less adequate provision of nutrients, weight 
gain and worse blood count profile compared with standardised protocols. The prescription of 
different physicians can be easily affected due to subjective factors such as the current 
clinical status of the infants and lead to less aggressive prescriptions.  
Figure 1 shows an example of individualised PN composition.  
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Figure 1. Individual composition of parenteral nutrition according to a protocol prescribed by 
individual physicians including protein, carbohydrates and micronutrients (bag) as well as fat 
and vitamins (syringe).   
 
Optimal nutritional intakes during the first week of life are difficult to reach and the risk for 
increased cumulative nutritional deficits is large (12-15). In a recent Belgian study, the 
nutritional protocol was adapted to current guidelines for EPT infants (16-18). The infants 
received 40 kcal/kg/d and 2.5 g protein/kg/d the first postnatal day and 120-130 kcal/kg/d 
with 3.8-4.4 g/kg/d of protein by the end of the first postnatal week (28). As a result, the 
optimised nutritional intakes during the first week lead to improved growth and a reduction in 
postnatal cumulative nutritional deficits. Furthermore, the use of PN with an optimised, 
standardised, ready-to-use solution contributed to improving the early nutritional supply.  
In a randomised clinical trial (RCT), Morgan et al showed that premature infants who 
received a standardised, concentrated PN solution during the first 28 days of life ameliorated 
their head growth (29). Miller at al. showed improved nutritional intakes and growth by 
implementing a nutrient based-protocol warranting sufficient energy and protein intakes 
during the transition phase of nutrition when PN is weaned with advancing enteral feeds (30). 
In a randomised double-blind controlled trial by Uthaya et al, premature infants were divided 
into four groups each receiving one of four PN solutions that differed in lipid composition 
and amount of amino acids provided during the first day of life (31). Expected differences 
between the four groups regarding amounts of intra-hepatocellular lipid and lean body mass 
were not demonstrated. The amount of 3.6 g amino acids intake on day one did not benefit 
body composition nor growth to 36 postnatal weeks and may be harmful.  
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1.3.2 Enteral nutrition 
Human Milk (HM) delivers optimal nutrients for infant growth, enables maturation of the 
intestine, microbial colonisation and intestinal motility (21, 23). Important outcomes such as 
risk for necrotising enterocolitis (NEC) and late onset sepsis may be associated with the 
timing of introduction and the rate of advancement of enteral HM feeds (32, 33). Colostrum 
is breast milk produced during the first postnatal days after birth, Figure 2. During six 
postnatal weeks after birth the protein content in breast milk decreases to be less than half of 
the colostrum content (34).  
Giving small volumes (12-24 ml/kg/d) of 
HM without advancing the feed volumes 
during the first five to seven days after 
birth is defined as early trophic feeding 
(35). The definitions for early and delayed 
introduction of HM feeds are up to four 
days and later than five to seven days of 
postnatal life, respectively (36). 
Furthermore, slow and fast advancement 
as daily increments of HM feeds are 
defined as 15-20 ml/kg/d and 30-35 
ml/kg/d, respectively (37). 
  
© Karolinska University Hospital  
Figure 2. Colostrum in syringe.  
 
 
Delayed introduction and slow advancements of enteral feeds prolong the need for PN and 
also the time to regain birth weight. However, the long- term clinical importance of these 
effects is still unclear. Compared to premature formula, HM is associated with shorter 
hospital stay (38) and lower incidence of re-hospitalisation (39). Mother’s own milk (MOM) 
or donor breast milk (DHM) is always the first-hand choice for EN in Swedish NICUs (40). 
The health benefits of HM have been increasingly recognised (41). MOM is given to the 
preterm infants as long as the milk production last. When MOM production is suboptimal, a 
complement with DHM is given, until the infant reach a postnatal age of at least 32-35 
weeks. Premature formula can be used at the earliest at 32 weeks of postnatal age but only 
when supply of MOM is insufficient or terminated (42). Macronutrients’ content in MOM 
and DHM are analysed on a regular base (43). Mid-infrared spectrophotometry has been used 
to determine macronutrient content in dairy products for many years. When calibrated for 
measurement of macronutrients in HM, the mid-infrared spectrophotometry technique 
facilitates individual fortification of HM (44, 45). As macronutrients’ content in HM changes 
over time, especially regarding protein (46), regular macronutrient analyses of MOM are 
needed, preferably at least weekly during the first postpartum weeks (47). Early MOM, 
expressed during the first 28 postnatal days usually contains more protein especially during 
the first two postnatal weeks compared to mature MOM (>28 days), Figure 3, in contrast to 
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DHM’s lower protein content because of its earliest expression after the first two postnatal 
weeks (48). 
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Figure 3. Differences in colour and nutrient content of mothers own breastmilk. 
Nutrient content g/100 ml Protein Fat Carbohydrate 
MOM A 1.0 2.2 7.1 
MOM B 1.4 4.0 7.2 
MOM C 1.0 3.2 7.4 
 
In Sweden, there are 28 human milk banks (49), which is the highest number per capita in the 
world. To be able to follow specific safety guidelines DHM should be provided from 
established human milk banks (50). Some biological components in DHM are reduced by 
the storage and processing and may diminish the health benefits. The focus of future 
research should be on the improvement of milk processing in human milk banks, 
particularly of heat treatment and optimisation of HM fortification. Furthermore, research is 
needed to investigate the potential clinical benefits of processed and fortified DHM.  
During the last decades, most research regarding EN is based on fixed amounts of 
fortifications or standardised fortification, in HM that has not been analysed, assuming an 
average content of macronutrients and energy in HM (51-54). Since there is an inter- and 
intra-individual variation of the composition in HM, target dosage by individualised 
fortification rather than standard fortification should be applied to avoid under- or over 
nutrition of the infant, Figure 4 (46, 47, 55-62).  
A
 
B
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Figure 4. Bar chart demonstrating four hypothetical fluid restricted infants (160 ml/kg/d) on 
standard fortified mothers’ own milk and donor human milk (0.8 g protein per 100 ml). The 
black line denotes estimated nutritional needs for full enteral feeds, including 135 kcal/kg/d, 4 
g protein/kg/d and 7 g fat/kg/d (47E %), according to The Swedish Board of Health and 
Welfare (20).   
 
Another type of individualised fortification is called adjustable fortification using blood urea 
nitrogen values twice a week to assess the amount of HM fortifications needed with regard to 
protein (63). This can delay increases in protein intake which allows malnutrition to some 
extent. Moreover, blood urea nitrogen does not give any information regarding energy and fat 
intakes.  
 
1.4 ESTIMATED NUTRITIONAL REQUIREMENTS 
American and European guidelines published during 2005 and 2010 (16-19), differ slightly 
compared to contemporary guidelines (64, 65). Based on previous guidelines, in 2014, The 
Swedish National Board of Health and Welfare published nutritional guidelines for extremely 
preterm infants born before 28 completed weeks of gestation, Table 1 (20).  
Table 1. Nutritional guidelines for extremely preterm infants according to The Swedish 
National Board of Health and Welfare. 
 Day 1 Day 4 Enteral nutrition 
full dose 
Total parenteral 
nutrition 
full dose 
Unit 
(/kg/d) 
Energy 50-60 100-120 115-135 90-115 Kcal 
Protein 2.0-2.4 3.5-4.5 4.0-4.5 3.5-4.0 g 
Fat 1.0-1.5 4.0-6.0 5.0-8.0 3.0-(4.0) g 
Carbohydrate 8.0-11.0 10.0-15.0 9.0-15.0 11.4-14.4 g 
Fluid 80-120 130-160 135-200 135-180 ml 
% 
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1.4.1 Energy 
In infancy, resting energy expenditure (REE) is the appropriate method used to measure the 
amount of energy needed to maintain the vital processes of the body in stable infants (65). 
REE is not higher than 10 % compared to the basal metabolic rate and can be measured in a 
thermo-neutral environment, most suitable before feeding or after a fasting period. REE is 
decreased in hypothermia and increased in conditions such as e.g., fever, inflammation and 
chronic diseases. To date, there are no Schofield’s equations for calculating REE for 
premature infants.  
Energy supply should cover basal metabolic rate and growth and also compensate for 
negative energy balance. Nevertheless, according to a recent study, PN practices are 
frequently not compliant with current guidelines, especially during the first postnatal days of 
life (66). Swedish guidelines suggest the intake of 50-60 kcal/kg/d on the first day of life and 
intake of 90-115 kcal/kg/d from full PN, Table 1 (20). In contrast, recent ESPGHAN 
guidelines recommend 45-55 kcal/kg/d on the first day of life regarding premature neonates 
and 90-120 kcal/kg/d from full PN including extremely low birth weight infants (65). 
Transition time from PN to full EN in extremely preterm infants can take up to several weeks 
(67). Swedish guidelines suggest the intake of 115-135 kcal/kg/d from full EN, Table 1 (20). 
According to these guidelines, an energy intake of 100-120 kcal/kg/d, consisting of 50 % EN 
and PN is proposed already on the fourth day of life.  
To calculate energy in kilocalories (kcal), energy factors by Atwater’s are used (68). The 
energy factor is 4 kcal per gram and 9 kcal per gram for protein, carbohydrates and fat, 
respectively. However, the energy available from macronutrients differs between PN and EN. 
Because of higher splanchnic tissue metabolism and stool losses, energy requirements are 
generally 10-20 % higher with enteral feeds are compared to PN (69-72). 
 
1.4.2 Protein 
Because of the need of invasive methods, little is known about the protein requirements or 
metabolism in the human foetus (73). The body composition analysis of still born preterm 
infants constitutes the basis for the current available standards for intrauterine protein 
accretion, suggesting that the foetus during the third trimester grows at about 15 g/kg/d.  
Furthermore, the protein accretion is approximately 2 g/kg/d and decreases slowly towards 
term age (26). Net protein accretion by protein synthesis exceeding the protein break down, is 
necessary to increase the lean body mass. In the preterm infant, the protein synthesis exceeds 
the protein intake leading to protein turnover since proteins are continuously broken down in 
the body and resynthesized (73). According to the nitrogen balance method approximately 
1.5 g/kg/d is initially needed for a neutral net protein accretion rate (18). 
Swedish guidelines suggest a protein intake of 2.0-2.4 g/kg/d on the first day of life and a 
protein intake of 3.5-4.0 g/kg/d from total PN (20). Recommendations regarding protein 
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intakes are different depending on the new-born infant’s birth weight. According to the 
Swedish guidelines, the protein intakes should be 4.0-4.5 g/kg/d for EPT infants weighing 
1000 gram or less and 3.5-4.0 g/kg/d for those weighing between 1000 gram to 1800 gram 
(20). On the fourth postnatal day if fluid intakes, consisting of 50 % EN are reached, Swedish 
guidelines stipulate protein intake of 3.5-4.5 g/kg/d (the higher amount for infants < 1000 
grams).  During the last decades, several studies have highlighted the importance of sufficient 
early amino acid supply for a positive protein accretion rate (74-78). To facilitate maximal 
protein accretion, energy intake of at least 120 kcal/kg/d is the aim of most practitioners (79, 
80). Since it is likely that protein and other nutrients are limiting factors regarding growth, 
protein to energy (PE) ratios were calculated, based on grams of protein provided per 100 
kcal. The ideal PE ratio is yet not known (65) and different PE ratios such as 3.2 to 4.1 g 
protein per 100 kcal (18) and 3.1 to 3.3 g/100 kcal (81) are suggested in recent literature. 
 
1.4.3 Fat  
Fat contains about twice as much calories per gram compared to other macronutrients and is 
therefore an effective source of energy. Failure to provide fat as soon as possible after birth 
may cause suboptimal calorie intake and proteolysis (16). The intrauterine provision of fat is 
low (82) and the EPT infant have low fat stores at birth. Furthermore, it is difficult to meet 
estimated nutritional fat needs because of reduced digestion and absorption from the 
intestines (83) and reduced enzyme activity in DHM due to pasteurisation (84). Recent 
studies have demonstrated positive effects of early parenteral fat on nitrogen balance and 
thereby improved conditions for anabolism (77, 85). Vlaardingerbroek et al demonstrated 
higher nitrogen balance on day 2 and lower plasma urea, when a high dose parenteral lipids 
of 2.0-3.0 g/kg/d were combined with 2.4 g amino acids from birth (77). Moreover, higher 
intakes of fat (3.0 g lipids/kg/d) and amino acids (3.5 g/kg/d) already on the first postnatal 
day were well tolerated (85). However, fat malabsorption is common among preterm infants 
because of an immature exocrine pancreatic function at birth (83). A Swedish study of 29 
preterm infants born between 32 and 37 postnatal weeks, demonstrated at full term age a 
higher percentage of body fat when compared with new born infants matched for body 
weight and GA (86).       
Furthermore, fat also supplies essential fatty acids, which are needed for the structural 
composition and the myelination of the brain and retina (87). The long chain polyunsaturated 
fatty-acid (LC-PUFA) n-6 is potentially pro-inflammatory and the main source of lipids in 
several PN solutions. A reduction PN solutions containing soybean oil (n-6 fatty acids) may 
be indicated in premature infants with lung function problems since n-6 influence the 
pulmonary vasculature (88, 89). Alternative emulsions containing oil mixtures, rich in olive 
oil (n-9) are preferred since they reduce the risk of sepsis and promote a more favourable LC-
PUFA profile. A recent RCT in extremely preterm infants on PN, supplemented with 
SMOFlipid®, containing 15 % fish oil (n-3 fatty acids), demonstrated neither reduction of 
morbidity nor effect on growth (90). Furthermore, docosahexaenoic acid (DHA) was 
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marginally increased and arachidonic acid (ARA) to DHA ratio was decreased. More studies 
regarding DHA and ARA are needed since EPT infants accumulate a large deficit of these 
essential fatty acids.  
According to Swedish guidelines the fat intake from PN and EN is 3.0-4.0 g/kg/d and 4.0-8.0 
g/kg/d, respectively, (20). Already on the fourth postnatal day the recommended fat intake of 
4.0-6.0 g/kg/d and fluid intakes, consisting of 50 % EN should be reached in EPT infants’ 
nutrition. Swedish guidelines stipulate enteral fat intake of between 40 and 55 Energy %, 
corresponding to approximately 8.0 g fat/kg/d or even more.  
 
1.4.4 Carbohydrates 
Carbohydrates and specifically glucose are the most important sources for many metabolic 
processes and particularly for the brain and the heart in the preterm infant (17). A minimum 
glucose intake of 4.0 mg/min/kg, approximately 7.0 g/kg/d is needed to meet the glucose 
requirements of the brain (91). The novo synthesis of fatty acids and a number of non-
essential amino acids is provided by carbon in glucose (64). During the first days of life, most 
preterm infants produce endogenous glucose corresponding to 4.0-5.0 mg/min/kg from both 
glycogenolysis and gluconeogenesis (92, 93). There is a risk for hyperglycaemia during the 
first postnatal week because of sustained endogenous glucose production despite supply of 
parenteral glucose. A common way to treat infants’ hyperglycaemia is to reduce glucose 
infusion. Insulin treatment favours nutritional intake but is seldom used in Sweden (94). 
Swedish guidelines recommend a parenteral carbohydrate intake of 13.0-17.0 g/kg/d (20).  
Lactose is a disaccharide composed by galactose and glucose the main carbohydrate in HM, 
and the enzyme lactase in the small intestine is necessary for reduction and absorption (25). 
In preterm infants, lactase activity is 30 % lower, compared to term infants, causing lactose 
malabsorption. Malabsorption of lactose is detrimental for preterm infants’ health, leading to 
feeding intolerance, delayed attainment of full enteral feeds, and poor weight gain (95-97). 
Shulman et al found that higher lactose absorption in preterm infants was more related to 
improved lactase activity than to mucosal growth (98). Moreover, a relation was showed 
between enteral feeds and mucosal growth. Swedish guidelines recommend an enteral 
carbohydrate intake of 9.0-15.0 g/kg/d (20). On the fourth postnatal day if EN reaches 50 %, 
the recommended carbohydrate intake is 11.0-16.0 g/kg/d.  
 
1.5 POSTNATAL GROWTH 
Despite improved neonatal care and enhanced neonatal nutrition during the last decades, 
postnatal growth in premature infants is still suboptimal (12-15, 99). Since optimal growth 
standards have not been defined, the optimal growth of preterm infants is considered to be 
equivalent to intrauterine growth patterns of the foetus (18, 19, 100). 
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1.5.1 Growth charts 
In the beginning of the1990s, Gardosi and colleagues introduced a standard, longitudinal 
ultrasound-derived growth curve for intrauterine weight gain, customised for each individual 
pregnancy, taking the mother's characteristics and birth weights from previous pregnancies 
into consideration (101). Growth curves based on data from four Scandinavian NICUs 
regarding ultrasonically estimated foetal weights in uncomplicated pregnancies was 
performed in 1996 by Marsal et al (102). Later on, Niklasson and Albertsson-Wikland 
introduced continuous and smoothed, gender specific growth reference values from 24th week 
of gestation to 24 months of age, based on a Swedish national birth cohort between 1990 and 
1999 (103). These curves, also based on estimated normal growth in utero, are suitable 
especially for the follow-up of preterm infants because of the visual presentation of age 
corrected growth curves. However, most published postnatal growth trajectories for preterm 
infants have been established by studying NICU cohorts, inevitably consisting of a mix of 
sick and healthier infants (104-108).  Figure 5 demonstrates growth curves in Nutrium, based 
on Niklasson and Albertsson-Wikland’s gender specific growth reference values. Apart from 
a calculating tool, Nutrium is also used to visualise premature infants’ growth in many 
Swedish NICUs. 
 
 
 
 
Weight 
Length 
Head circumference 
 
A 
Gestational age (weeks) 
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© Nutrium AB 
Figure 5. Growth charts in Nutrium according to Niklasson and Albertsson-Wikland, 
demonstrating growth during a seven weeks’ period of an extremely premature infant born 
before 25 weeks of gestational age and a weight of 711 grams, visualised as standard 
deviation scores (A) and weight growth curve in grams (B). The black dotted lines denote 
estimated normal growth in utero.  
 
In 2004, the WHO published a multicentre growth reference study considered as preferred 
standard for postnatal growth (109). Those postnatal growth charts begin at term age and 
should not be used to assess preterm postnatal growth before 36 completed weeks of 
gestation. The Paediatric societies in Europe (18) and North America (19) have 
recommended that the aim of nutritional guidelines is to generate optimal postnatal growth 
matching the in utero growth and mimicking the foetal body composition until full term. In 
2010, Olsen et al published new intrauterine growth curves based on contemporary, large, 
ethnically diverse, American data (110).  
In a systematic review and meta-analysis, Fenton et al demonstrated the revised preterm 
growth chart, in accordance with the WHO standard at 50 weeks’ postnatal age (111). These 
growth patterns may support an improved transition of preterm infant growth monitoring of 
the WHO growth trajectories and show a gender specification regarding premature infants. In 
2016, Rochow et al provided target trajectories for extrauterine growth after completed 
postnatal adaption, based on healthy preterm infants born between 25 and 34 weeks of 
gestation with little or no clinical interventions required (112). 
 
1.6 NUTRITIONAL INTAKES AND POSTNATAL GROWTH  
One of the critical limitations of using preterm infants as a growth reference is the changing 
growth pattern caused by the improvement of preterm nutrition and medical care (106). 
Rochow et al demonstrated a shift in the infants’ postnatal trajectory by -0.8 standard 
deviation scores (SDS) caused by an irreversible contraction of extracellular water space 
B 
Gestational age (weeks) 
Weight (g) 
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during the first postnatal days (113-118) and by the abrupt lapse of placental nutritional 
supply, Figure 6 (112). The sudden lack of placental nutritional supply after birth combined 
with suboptimal nutritional support such as delayed postnatal enteral feeding advancement, 
prolonged use of suboptimal PN and repeated incidences of feeding intolerance increases the 
risk for nutritional deficit in the premature infant.  However, this observed postnatal offset 
might be temporary and disappear with optimal nutrition, normal environmental conditions 
and under normal physiology.  
 
© Niels Rochow 
Figure 6. Postnatal offset of growth charts illustrated by the course of one hypothetical 
infant. Dotted (blue) and solid (red, blue) lines represent intrauterine and postnatal growth 
curves, respectively, and solid (yellow) space represents the deviation from intrauterine 
growth curve. The hypothetical infant’s intrauterine growth is along the 50th percentile (1) but 
deviates after birth from the intra uterine growth curve due to redistribution of fluid (2) 
according to Fenton et al (106). The infant’s continued growth is on a curve parallel to its 
peers still in utero, but after 42 weeks, back to the 50th percentile (3) according to WHOs 
postnatal charts (109). In recent guidelines of Joosten et al, a weight gain of 17-20 g/kg/d was 
recommended for very low birth weight infants to prevent continued weight drop across the 
centiles after the postnatal nadir of weight loss (65).  
 
There is a lack of standardised approach to report growth and nutritional intake data in 
neonatal literature (119). An important factor contributing to the lack of progress in this field 
is the variability in reporting which makes it difficult to compare studies and to rely on meta-
analysis. To facilitate the use of nutrition and growth data, Cormack et al proposes the 
Checklist-Standardized Reporting Of Neonatal Nutrition and Growth (StRONNG) (119). 
Because of improved survival rates of very preterm infants, the focus of neonatal care has 
shifted onto improving postnatal growth and nutrition to achieve growth rates to optimise 
later health outcome (120). Recent studies show that there is a relationship between given 
nutrition and growth during the neonatal period (29, 52, 99). Nutritional outcomes in these 
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studies are based on detailed information on nutritional intakes regarding energy and macro-
nutrients in PN and EN, respectively.  
A prospective cohort study, including preterm infants showed a lower growth rate compared 
to the intrauterine growth curve despite achieving energy and protein intakes close to recent 
nutritional recommendations (121). Another study demonstrated a reduction in postnatal 
cumulative nutritional deficit and an improvement of growth in preterm infants born before 
31 weeks of gestation infants, when optimising the nutritional practice in the NICU (28). In 
conclusion, it is difficult to achieve optimal nutrition to generate optimal growth, and more 
evidenced based research in this field are warranted. 
 
1.7 NEONATAL MORBIDITY AND NUTRITION 
The third trimester is very important regarding organ development, not at least regarding the 
brain (122). Conditions for normal growth and development are changed by preterm birth. 
Preterm infants, particularly the smallest ones, suffer from several different neonatal 
problems due to immaturity at birth, short- and long-term morbidity occur at a higher content 
with decreasing GA (123-126). Lower BW compared to GA is in itself a risk factor for 
morbidity (127). Clinical risk index for babies (CRIB) is used to establish severity of neonatal 
morbidity (128). In this neonatal score system, in which high CRIB score is equal to high 
risk, and information during the first twelve hours of life regarding e.g., BW, GA, presence of 
congenital malformations, maximum and minimum expired oxygen are included. Increased 
risk of cerebrovascular complications has been associated with a high CRIB score (125). The 
Apgar-score was developed in the beginning of the 1950s, this is a well-used system to 
determine infants’ condition at birth (129). Characteristics such as heart rate, respiratory 
effort, muscle tone, irritability and colour are scored at one, five and ten minutes after birth. A 
score of seven or higher, based on characteristics assigned value of maximum two, indicates 
good or excellent condition of the new-born infant. 
 
1.7.1 Bronchopulmonary dysplasia  
Premature infants born between 23 to 30 weeks of gestation are at risk for bronchopulmonary 
dysplasia (BPD), a respiratory disorder that usually occurs after respiratory distress syndrome 
(130). Some infants suffering from severe lung disease require supplemental oxygen during 
several weeks and sometimes months after birth (131). The most accepted clinical definition 
for severe BPD is defined as the need for at least 30 % oxygen at 36 weeks of GA (132). 
Several studies showed that suboptimal growth increases the frequency of BPD in preterm 
infants (127, 133, 134).  Approximately 50 to 80 % of EPT infants are affected of BPD a 
disease originating from impaired development of the lungs (123, 125). Incidence and 
severity of BPD has been associated with suboptimal growth among ELGA infants (135-
137). One RCT observed a reduction in occurrence of BPD when preterm infants born <30 
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weeks of gestation were fed with fortified DHM compare to premature formula (138). To 
date, this RCT is the only one performed with fortified DHM.  
 
1.7.2 Retinopathy of prematurity 
Approximately 50 to 80 % of EPT infants are affected by retinopathy of prematurity (ROP), a 
disease originating from impaired development of retina (123, 125). Infants born extremely 
preterm are at high risk to develop ROP, leading to high risk of visual impairment and of 
blindness. Well known risk factors for ROP development are prematurity itself, low birth 
weight, oxygen exposure (139) and poor weight gain during the first weeks of life (140, 141). 
Disturbed vascular development of the retina is the cause of ROP. There are five severity 
stages in ROP detected by eye examination (142) and stage 3-5 is considered severe ROP. 
Incidence and severity of ROP has been associated with suboptimal growth among ELGA 
infants (135, 137, 143).   
In a randomised clinical trial (RCT), the intervention group that had higher initial infusion 
rate of parenteral lipids, leading to higher energy intake during the first postnatal week, had a 
lower rate of ROP (144). Energy intake at the lowest quartile the first 28 postnatal days was 
associated with increased risk of severe ROP, according to a study of Vander Veen et al 
(145). In the EXPRESS cohort, the association between nutrition and ROP development was 
also investigated, demonstrating that a 10 kcal/kg/d increase in energy intake the first 28 
postnatal days, adjusted for morbidity, was associated with a decreased risk of severe ROP 
(146). Contrary to higher intakes of energy, fat and carbohydrates, protein was not associated 
to a lower risk of severe ROP.  
 
1.7.3 Patent ductus arteriosus  
Patent ductus arteriosus (PDA) is a common neonatal morbidity. In the EXPRESS cohort 
61 % of infants required treatment for PDA (125). In utero, a blood vessel called ductus 
arteriosus connects the main pulmonary artery to the descending aorta, Figure 7. In term 
infants the ductus closes within the first 24 to 48 hours after birth (147), while spontaneous 
closure in preterm infants often is delayed. Furthermore, the closure rate declines in preterm 
infants born at low gestational ages (148).  
Shunting of blood from the aorta to the pulmonary artery (left to right shunt) occurs through 
the PDA when flow resistance of the lung cycle decreases (20). With a large PDA, 
symptoms such as increases in respiratory rate and heart rate arise as well as increases in 
oxygen dependency and respiratory support. Other complications due to a large PDA might 
be heart failure, apnoea, fall in blood pressure and kidney failure. Moreover, a large PDA 
affects postprandial perfusion of the superior mesenteric artery and is associated with 
impaired feeding intolerance (149) causing e.g., extended time to full enteral feeds (150). 
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When PDA causes hemodynamic effects, the first line of treatment is with pharmaceuticals 
(Ibuprofen or Indomathacin) and the second line of treatment is with surgical ligation (151). 
Today, there is no consensus about optimal postnatal age for pharmaceuticals or ductal 
ligation for PDA (152, 153). PDA in preterm infants is associated with increased risk for 
other morbidities, such as BPD, intraventricular haemorrhage and NEC (154). However, it 
is unclear if this association is with the hemodynamic effects of the left-to-right shunt; the 
pharmacological/surgical treatment, or the immaturity (151). Physiological preoperative 
stabilisation is necessary including the withholding of enteral feeds during at least 6 hours 
prior ductal ligation (155).  
 
 
© Stefan Johansson 
Figure 7. Blue, including numbers one, two and three denotes right atrium, right ventrical 
and pulmonary artery, respectively. Red, including numbers four, five, six, seven and eight 
denotes left atrium, left ventrical, aorta, aorta archs and ductus, respectively.  
 
A Cochrane review showed a decreased risk of PDA with restricted fluid intake during the 
first days after birth in preterm infants (156). Fluid restriction makes it much more difficult 
to achieve adequate nutritional supply and the need of more concentrated nutritional 
products such as parenteral solutions might therefore be necessary to reach nutritional goals 
for ELGA infants.  
 
1.7.4 Necrotising enterocolitis  
Necrotising enterocolitis (NEC) is an inflammatory bowel necrosis and is the major cause of 
morbidity and mortality in EPT infants (157). Any segments of the intestine may be involved 
8 
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but the terminal ileum and the proximal colon are at highest risk for being affected. The 
classification system including three different stages was presented by Bell et al in 1978 and 
modified by Kliegman and Walsh nine years later, is used for determining the severity of 
NEC (158, 159). The incidence of NEC in Sweden and USA is 5.8 % among infants with GA 
<27 weeks (125) and 11 % among infants with GA <29 weeks (123), respectively.  
Several studies from the last decades found that HM feedings in the NICU are associated 
with decreased morbidity and mortality, regarding NEC (51, 138, 160-163). Three systematic 
reviews (164-166), comparing DHM versus formula suggest that DHM has a protective effect 
against NEC in premature infants. Today, there is lack of evidence regarding the effect of 
individualised fortified HM on tolerance and incidence of NEC. Current evidence from the 
Cochrane reviews suggest that the introduction of HM before the postnatal age of four days 
and the advancement of the rate of feed volumes at more than 24 ml/kg/d do not increase the 
risk of NEC in VLBW infants (167). A recent American study found no differences in NEC 
rates, comparing infants fed exclusively preterm formula with infants receiving mixed diet 
containing less than 98 % of HM (168). In this study, HM was fortified (standard 
fortification), but no information about type or quantity of the bovine milk based fortifiers 
(BMBF) was supplied. Other studies showed a reduction in the probability of requiring PN 
(169) and lower rates of NEC (170) when HM was fortified with human milk based fortifiers 
(HMBF) instead of BMBF. One group received HMBF, while the other group received 
BMBF and premature formula. A recent RCT could not demonstrate differences in feeding 
tolerance among infants born below 1250 grams who were fed with MOM and or DHM 
fortified with either HMBF or BMBF (171).  
Osmolality is the number of osmoles of a solute in a kilogram of solvent, reflecting the 
solute’s concentration, expressed in mOsm/kg. Osmolality of feeds vary, the lowest values, 
300 mOsm/kg are found in HM and the highest values, just more than 400 mOsm/kg in fully 
fortified HM (172). Moreover, mineral and vitamin supplements added to small volumes of 
milk should be avoided if possible, since osmolality can be highly increase. High osmolality 
of enteral feeds delays gastric emptying and has been linked to the pathogenesis of NEC 
(173, 174). However, Pearson et al did not found evidence for a connection between 
osmolality of feeds and the development of NEC (172). 
 
1.7.5 Other morbidities 
Infections in preterm infants occur frequently and sepsis is a common serious condition. In a 
recent Cochrane review, the association between nosocomial infections and the use of 
percutaneous central venous catheter and peripheral cannulae was assessed (175). The 
prevalence of catheter-related sepsis in the NICUs reached 40 %, depending on the 
population studied (176-178). A vicious cycle emerges, starting with feeding intolerance, 
slow advancements of EN and outstretched need of vascular access for PN subsequently 
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leading to sepsis. Growth failure has been associated with sepsis, but not GA or BW in a 
Swedish population based study (125). 
Intraventricular haemorrhage (IVH) is a brain injury that evolves during the first week of life, 
particularly, the first three postnatal days (179). IVH are classified into four different grades 
of which grade three to four are rated as severe IVH (180). IVH grade 3 and grade 4 are IVH 
with ventricular dilatation possibly leading to hydrocephalus and intraventricular bleeding 
leading to infarction in the brain parenchyme, respectively.    
 
1.8 LONG-TERM OUTCOME 
Long-term outcomes such as suboptimal neurodevelopment and cardiovascular risks factors 
are common present in preterm infants. Extremely premature infants are at increased risk of 
neurodevelopmental disabilities, including cerebral palsy, cognitive disability, and disabilities 
caused by vision and hearing impairments (181). There are associations between both BPD 
and severe ROP (grade >3) and higher risk of morbidity, including neurocognitive 
impairment in adult life (182, 183). Accordingly, preterm birth has become an important 
public health issue. Both suboptimal nutrition and poor growth during vulnerable periods of 
development have been associated with impaired neurodevelopmental outcomes in preterm 
infants (184-191). Poor postnatal growth caused by insufficient energy and macronutrient 
intakes has been associated with poor neurodevelopmental outcome (184).  
The only RCT in which preterm infants received either unfortified DHM or premature 
formula without confounding by the mother’s decision to breast feed was performed in the 
early 1980s (192). In a follow-up study of Singhal et al, blood pressure (193) and plasma 
lipoprotein profile (194) were measured at the age of 13-16 years, in 23 % of a cohort of 926 
children who were born prematurely and had participated at birth in two parallel randomised 
trials in five neonatal units in the UK. Lower mean blood pressure and more favourable 
plasma lipid profile with a lower ratio of low-density to high-density lipoprotein cholesterol 
compared to those fed with premature formula, were seen in adolescents who had randomised 
to receive DHM during neonatal period, either as sole diet or a supplement to MOM. In 
contrast to the hypothesis that rapid early growth may influence later metabolic risk factors 
(195), Henriksen et al found no associations between rapid weight gain during the first year 
of life and metabolic markers, such as cholesterol, fatty acids, insulin growth factor 1, 
adiponectin, leptin and HbA1c (196). 
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2 OBJECTIVES 
The overall objective of this thesis was to increase knowledge regarding extremely preterm 
infants’ nutritional intakes over time and during the perioperative week surrounding 
surgical treatment for PDA. This thesis focuses on early and perioperative nutrition and 
investigate implemented changes and associations with growth, BPD and ROP as well as 
differences between NICUs regarding perioperative nutrition. 
Specific objectives of the included studies were: 
Paper I  
To describe interventions regarding nutritional intakes in Stockholm, Sweden between 2004 
and 2011 and to investigate if energy and macronutrient intakes in and growth of extremely 
preterm infants have increased over time. 
Paper II 
To investigate if higher energy- and protein intake the first week of life and the first month of 
life were associated with reduced initial weight loss and reduced risk of ROP and BPD in 
extremely preterm infants, respectively.      
Paper III 
To describe perioperative nutrition, including energy-, macronutrient- and fluid intakes, 
during the week surrounding ductal ligation for PDA in extremely preterm infants born in 
Sweden between 2004 and 2007.  
Paper IV  
To describe differences in perioperative nutrition between Swedish NICUs during the years 
2004 to 2007. 
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3 METHODS 
3.1 STUDY POPULATION AND DATA COLLECTION 
All four papers in this thesis are retrospective observational studies.  
Overview of the thesis’ four papers 
Paper Research question Exposure Outcomes Statistics 
I To investigate if 
nutritional 
interventions 
improved energy 
and macronutrient 
intakes as well as 
growth. 
Nutritional 
interventions 
including e.g., 
guidelines 
update, 
aggressive 
nutrition, ward 
staff education, 
ready-to-use PN 
solutions. 
Energy- and 
macronutrient 
intakes, growth. 
Descriptive 
statistics, quantile 
regression with 
bootstrapped 
confidence 
intervals. 
II To investigate 
association of 
higher energy- and 
protein intake 
during the first 
week and month of 
life related to 
growth and 
morbidities.    
Energy- and 
protein intake 
measured during 
the first week and 
month of life. 
Growth as well as 
occurrence of 
composite (death 
or BPD) and 
ROP/BPD. 
Multiple variable 
adjusted linear 
regression, 
Poisson 
regression. 
III To investigate 
nutritional intakes 
during the week 
surrounding day of 
PDA surgery. 
Perioperative 
week starting 3 
days prior and 
ending 3 days 
post-surgery  
Energy-, 
macronutrient- and 
fluid intakes. 
Descriptive 
statistics, one way 
ANOVA with 
Bonferroni. 
IV To investigate 
differences between 
NICUs regarding 
nutritional intakes 
during the week 
surrounding day of 
PDA surgery. 
Five Swedish 
NICUs. 
Energy-, 
macronutrient- and 
fluid intakes. 
Descriptive 
statistics, one way 
ANOVA with 
Bonferroni. 
 
3.2 STUDY POPULATION 
In all four studies infants born in Sweden at less than 27 postnatal weeks between 2004 and 
2011 and who survived >24 h, were included. In papers I and II, the study period comprised 
eight and four weeks, respectively. In paper II, infants were excluded if abdominal surgery or 
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transfer outside Stockholm occurred before the first outcome, e.g., before postnatal day 
seven, Figure 8. In papers III and IV, the study period comprised one week surrounding 
ductal ligation for PDA. In all papers, infants with major chromosomal or severe congenital 
anomalies were excluded as well as infants with incomplete nutritional data or missing data 
from the hospital records. 
 
 
Figure 8. Flowchart of infants included in Paper I and II.  
 
3.2.1 Papers I and II 
Paper I 
The Stockholm-study consists of the Stockholm section of The EXPRESS cohort (2004-
2007) and Stockholm research study (2008-2011).  
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© Susanna Klevebro  
Figure 9. Interventions affecting nutritional intakes between 2004 and 2011. PM (gray) 
denote local guidelines. 
  
The interventions that occurred during the study period were: Update of international and 
local nutritional guidelines, introduction of computer software facilitating nutrition evaluation 
and prescription and introduction of ready-to-use parenteral solution simplifying early start of 
protein and carbohydrates, Figure 9. Work related interventions were: Increased employment 
of dietitians, upgraded status for the milk kitchen staff to nutrition assistants and 
implementation of methods for documentation, as well as changes in nutritional practice 
regarding detailed PN and EN, Table 2. Energy- and macronutrient intakes as well as growth 
were investigated over eight-year period stratified by four year-groups. Infants eligible for 
inclusion were 348 and infants included in the final nutrition and growth analyses were 316 
and 300, respectively, Figure 8. 
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Table 2. Interventions in nutrition practices. 
 
Parenteral  
nutrition 
 
Start postnatal  
day 
 
Minimal and 
maximum 
macronutrient supply 
g/kg/d   
 
Postnatal day for 
optimal 
macronutrient supply 
 
Termination of 
parenteral fat infusion 
 
2004: International 
guidelines, 105-115 
kcal/kg/d (197) 
1 
 
0.5 to 3.0-3.5 protein 
0.5 to 2.5-3.0 fat 
Minimal 6-7 days 60 to 75 % provided as 
enteral nutrition 
 
2006: Local 
guidelines based on 
international 
guidelines, 105-115 
kcal/kg/d (17) 
 
0-1 
 
2.0 to 4.0 protein 
1.0 to 3.5 fat 
 
2-3 days regarding 
protein 
3-4 days regarding fat 
 
 
60 to 75 % provided as 
enteral nutrition 
 
2011: Local 
guidelines based on 
international 
guidelines, 105-115 
kcal/kg/d (17)   
 
0 
 
2.0 to 4.0 protein 
1.0 to 3.5 fat 
 
2 days regarding 
protein 
3 days regarding fat 
 
75 % provided as 
enteral nutrition 
 
Enteral  
Nutrition 
 
Start of breast 
milk 
fortification 
 
Maximum energy- 
and macronutrient 
supply, g and 
kcal/kg/d  
 
Postnatal day for 
optimal intakes  
 
Comments 
2004: International 
guidelines (197)  
100 % enteral 
nutrition 
 
3.8 g protein for infants 
weighing < 1000g 
6.6 g fat 
 
4 to 14 days Non aggressive feeding 
advancement strategy 
2006: Local 
guidelines based on 
international 
guidelines (17) 
100 % enteral 
nutrition 
 
4.0 g protein 
6.6 g fat 
150 kcal 
4 to 14 days 
 
Idem 
Change of protein 
fortifier from whole 
cow milk to extensively 
hydrolysed  
2010: International 
guidelines (18) 
75 % enteral 
nutrition 
 
4,5 g protein for infants 
weighing < 1000g  
8.4 g fat 
135 kcal 
2 to 7 days Aggressive feeding 
advancement strategy 
Adherence to the 
international guidelines 
occurred before 
publication 
 
Paper II 
The Stockholm-study consists of the Stockholm section of The EXPRESS cohort (2004-
2007) and Stockholm research study (2008-2011) with 348 eligible infants. Energy, protein 
(inclusive PE ratio) and fluid intakes as well intakes of transfusions were measured during 
early neonatal and late neonatal period. Outcome measurements were, growth as well as the 
occurrence of composite death or BPD and ROP/BPD. Analyses during the early neonatal 
period (0-6 days) regarding nutrition to growth, to composite death or BPD, and to ROP/BPD 
and during the late neonatal period (7-27 days) regarding nutrition to ROP/BPD were 
performed for 286, 285, 260 and 249 infants, respectively, Figure 8. Figure 10 a and b, show 
dietitian assistants in action in the ward kitchen. 
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© Ulrika Eriksson  
Figure 10 a. Dietitian assistants in the ward kitchen preparing individually fortified breast 
milk. 
 
© Ulrika Eriksson  
Figure 10 b. 
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3.2.2 Papers III and IV 
Paper III 
The subset of The EXPRESS cohort (2004-2007) with 141 eligible infants. The perioperative 
days were measured during one week starting 3 days prior to PDA ligation and ending after 3 
days post-surgery. Outcome measurements were, energy-, macronutrients- and fluid intakes 
per day/week. Analyses during perioperative week were stratified by gestational age and 
neonatal period in which surgical treatment was performed as well as compared to minimal 
estimated nutritional needs according Tsang et al (17) and Agostoni et al (18). Due to 
unobtainable nutritional data, one infant was excluded and finally 140 infants were included 
in the study.  
Paper IV 
The subset of The EXPRESS cohort with 141 eligible infants. The perioperative days were 
measured during one week starting 3 days prior to PDA ligation and ending after 3 days post-
surgery. Outcome measurements were, energy-, macronutrients- and fluid intakes per day and 
week. Differences of nutritional intakes during the perioperative week were investigated 
between five Swedish NICUs. Data were stratified by neonatal period in which surgical 
treatment was performed, type of fluid (EN, PN) and compared to estimated nutritional 
requirements. Due to unobtainable nutritional data, one infant was excluded and finally 140 
infants were included in the study.  
 
3.3 DATA COLLECTION 
For all studies, detailed nutritional data retrieved from hospital records and retrospectively 
registered in a nutritional software program (www.nutrium.se, Nutrium AB, Umeå, Sweden),  
included: All fluid intakes containing EN and PN, MOM, DHM, HMF, vitamin and mineral 
supplements, blood products, glucose infusions including electrolytes and anthropometrical 
data, Figure 11. The data-base comprised eight weeks of nutritional data regarding papers I 
and II, of which weeks one to four and five to eight were on daily (days 0-28) and weekly 
(day 35, 42, 49, 56) basis, respectively. Regarding papers III and IV, the data-base comprised 
one week’s (7 days) nutritional data. In total, 12116 (papers I, II = 11136, papers III, IV = 
980) postnatal days were registered in Nutrium. Data registration turned out to be very time 
consuming. It took up to four hours or more to register one infant in Nutrium.    
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 Figure 11. Calculation of energy (kcal/kg/d), macronutrients (g/kg/d) and fluid intake 
(ml/kg/d) in Nutrium, regarding one study infant. Red bars to the left of the middle line 
denote largely suboptimal intakes of energy and protein. 
 
In papers I and II nutritional data of all postnatal days during the eight postnatal weeks were 
used in the analyses. Missing data are presented in flowchart, Figure 8. In paper II, protein 
intake was evaluated as PE ratio, calculated as the fraction of the protein intake (g/kg/d) per 
100 kcal of energy intake (kcal/kg/d), if intake of energy was significantly associated with the 
outcomes. Nutritional intake of blood products was included in both papers II and III. Energy 
and protein estimated contents were 18 kcal/100 ml and 4.1 g/100 ml and 28 kcal/100 ml and 
6.9 g/100 ml regarding erythrocytes and plasma or thrombocytes, respectively (198, 199). In 
papers III and IV data included seven days during perioperative week starting three days prior 
and ending three days post-surgery for PDA. Of 980 possible days twelve were missing 
because of death (n=1, 2 days), incomplete nutritional data (n=3, 9 days) and transfer to 
county hospital (n=1, 1 day). Relevant perinatal data were retrieved from Swedish neonatal 
quality (SNQ) register and hospital records. Questionnaires inquiring nutritional practice 
during perioperative week were sent to NICUs, included in paper IV.  
Mid-infrared spectrophotometry was used to determine macronutrient content in HM 
(MilkoScan 4000, FOSS Hillerød, Denmark) at Eurofins Steins Laboratory AB, Jönköping, 
Sweden (48). MOM not analysed was equalled to the average content of the analysed MOM 
expressed from mothers of EPT infants before or after 28 postnatal days and used in 
nutritional calculations (48). DHM not analysed was equalled to the average content of 
analysed mature (> 28 days) HM samples. 
 
3.4 STATISTICAL METHODS 
Levene’s test was used to investigate the distribution of continuous data. The hypothesis of 
normality was rejected when the p-value < 0.05. If the test of normality failed, it allowed you 
to state with 95 % confidence, that the data did not fit normal distribution. However, passing 
the normality test only said that no significant deviation of normality was found.  
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3.4.1 Paper I 
Data were analysed in periods of two years (year-groups). To best illustrate data, median, 10th 
to 90th percentiles were used. Differences in nutritional intakes were examined using quantile 
regression with bootstrapped confidence intervals (200). Mixed effects model including 
restricted cubic splines were used to examine differences in growth (201, 202). 
 
3.4.2 Paper II 
Linear and Poisson regression with robust standard errors to study the outcome of interest 
was used (203). Associations with protein intake was evaluated as PE ratio (interaction term), 
if energy intake was significantly associated with outcome. If there was no measurement on 
postnatal day seven, that day’s weight was calculated assuming an exponential growth pattern 
between measurements within two weeks, according to Patel et al (204).  
Both risk for any ROP and severe ROP were examined when there was an association with 
risk of ROP. Differences in relative risk were calculated and expressed as risk ratios. To 
include predictors in the regression models, directed acyclic graphs were used as selection 
tool. Predictors as antenatal corticosteroids, GA in days, birth weight standard deviation score 
(BWSDS), sex, fluid intake, transfusions of erythrocytes and plasma, and days of MV were 
considered as potential confounders. Natural cubic splines were used to test linearity in the 
models, according Durrleman and Bassett (201). When the interaction term between MV and 
fluid intake was significant, potential interaction in the association between exposure and 
outcome was tested and supplemented with stratified analyses. Adjustments for period of 
birth’s analyses were also reported. An interaction term between energy intake and time 
period was included to test differences in association between time periods as time period 
(2004-2007 and 2008-2011) was included as a factor variable.  
 
3.4.3 Papers III and IV 
Descriptive statistics were presented in mean (SD), median, interquartile range (IQR) and 
numbers (%). One-way between-groups ANOVA with post-hoc tests was used to 
demonstrate differences regarding energy-, macronutrient and fluid intakes between 
perioperative days and NICUs (independent grouping variable with more than two levels). 
One-way ANOVA showed whether there were significant differences between the groups 
and post-hoc tests were used to identify the exact differences. Since intakes of EN and PN 
were not normally distributed, the non-parametric Kruskal-Wallis Test was used to show 
differences between NICUs regarding intakes of EN and PN.     
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4 RESULTS 
This section comprises the summary of the results of the four studies included in this thesis 
with the Stockholm section of the EXPRESS cohort and the Stockholm research study 
(Papers I and II) as well as the sub-cohort of EXPRESS study (Papers III and IV) 
 
4.1 INFANT CHARACTERISTICS 
Weight at birth was measured in 456 infants (316 in paper I and II, 140 in paper III and IV). 
Of all 489 (n=348 + n=141) infants, 50 died before 36 postnatal weeks of which 13 infants 
died <4 postnatal days, 12 infants died between postnatal days 4 and 9 and one infant died on 
postnatal day 16 (on day + 1 after PDA surgery). Of 456 infants 29 were born small for 
gestation (15 in paper I and II and 14 in paper III and IV). In Table 3 baseline and 
background characteristics are presented.     
Table 3. Infant characteristics at birth. 
 Paper I-II Paper III-IV 
Time interval, postnatal days 28-56 7 
Number of infants 316 140 
Gestational age, weeks 25.3 ± 1.1 24.8 ± 1.0 
Birth weight, g 784 ± 166  723 ± 156  
Birth length, cm 32.7 ± 2.4 (n=288) 32.0 ± 2.5 (n=102) 
Birth HC, cm 23.2 ± 1.5 (n=295) 22.8 ± 1.6 (n=108) 
Sex, male, n (%) 169 (53) 83 (59)  
Apgar score 
1 minute 4.9 ± 2.4 4.8 ± 2.6 
5 minutes 7.0 ± 2.3 7.1 ± 2.0 
10 minutes 8.4 ± 1.7 8.2 ± 1.5 
CRIB score 8.9 ± 4.5 (n=198) 7.7 ± 3.5 (n=136) 
Data are mean ± SD values or numbers (%) 
 
4.2 HIGHLIGHTS 
Paper I 
After exclusion of 32 infants due to chromosomal anomalies or severe malformations, 
missing data, death <day 4, 316 infants were included in this paper, Figure 8.  
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Highlights 
Energy and macronutrient intake improved over time.  
The amount of enteral nutrition was highest during the two-year period of 2008-2009. 
During the last two-year period (2010-2011), energy and protein intake approximately met 
minimal estimated needs, according to Swedish guidelines. 
Growth during later years improved compared to the first two-year period (2004-2005).  
 
Paper II 
After exclusion of 52 infants due to chromosomal anomalies or severe malformations, 
missing data, death <day 10, transferred <day 7 and abdominal surgery <day 7, 296 infants 
were included in this paper, Figure 8. 
Highlights 
Increased energy and protein intake during the first week reduced initial growth restriction. 
Increased energy intake during the first month of life is associated with lower risk for BPD 
and ROP. 
Increased energy and protein intakes during the first month of life are associated with lower 
risk for BPD for infants born during the years 2008-2011. 
The effect of increased nutritional intake and risk for ROP is less when mechanical 
ventilation is needed. 
 
Paper III 
After exclusion of one infant due to unobtainable data, 140 infants were included in this 
paper.  
Highlights  
Perioperative nutrition in Sweden is suboptimal compared to minimal estimated nutritional 
needs. 
Perioperative nutritional intakes of infants who received ductal ligation during early neonatal 
period are lower compared to those ligated during late neonatal and postneonatal periods.   
 
Paper IV  
After exclusion of one infant due to unobtainable data, 140 infants were included in this 
paper.  
Highlights  
Perioperative nutrition differs between Swedish NICUs. 
Fluid intake and distribution between enteral and parenteral nutrition differ largely between 
NICUs.   
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4.2.1 Papers I and II, improved nutrition and growth 
Energy, protein and fat intakes during the first postnatal week (days 0-6) improved over time, 
while differences regarding intakes between year-groups during days 7-27 were smaller, 
Figure 12 A, B, C. Protein intakes during the first postnatal week (days 0-6) and subsequent 
weeks (days 7-27) improved during the years but in year-group 2010-2011, only the protein 
intake during later part of the first postnatal week (days 4-6) met the minimal estimated needs 
for postnatal day four, according to the Swedish guidelines, Figure 12 B (20).  
Difference in median energy-, protein- and fat intake during days 0-3 between year-groups 
2004-2005 and 2010-2011 was 19 kcal/kg/d (95 % CI:16-22, p< 0.001), 1.9 g/kg/d (95 % 
CI:1.6-2.1, p< 0.001), 1.3 g/kg/d (95 % CI:1.2-1.5, p< 0.001), respectively, Figure 11 A, B, 
C. Difference in median energy-, protein- and fat intake during days 4-6 between year-groups 
2004-2005 and 2010-2011 was 21 kcal/kg/d (95 % CI:16-27, p< 0.001), 1.2 g/kg/d (95 % 
CI:1.0-1.4, p< 0.001), 1.3 g/kg/d (95 % CI:1.0-1.6, p< 0.001), respectively. Difference in 
median energy-, protein- and fat intake during days 7-27 between year-groups 2004-2005 and 
2010-2011 was 12 kcal/kg/d (95 % CI:6-18, p< 0.001), 0.5 g/kg/d (95 % CI:0.4-0.6, p< 
0.001), 0.2 g/kg/d (95 % CI:-0.6-0.9, p=0.61), respectively. 
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Figure 12. Median intakes of energy (A), protein (B) and fat (C) during postnatal days 0-3, 4-
6 and 7-27, stratified by year-groups. The black lines denote minimal estimated needs for 
postnatal day four, according to Swedish guidelines (20).  
 
The proportion of enteral feedings during days 0-6 was greater in year-group 2008-2009 
compared to year-group 2010-2011 and difference was 6.7 % (95 % CI: 2.2-11.2, p< 0.004).   
The feeding advancement in year-group 2008-2009 was faster compared to all other years 
and median time to full feeds was 15 (8-34) days. In contrast, median time to full feeds was 
23 (10-41) days in year-group 2010-2011. Nevertheless, higher total energy intake during 
days 7-27 compared to all other years was demonstrated in year-group 2010-2011 in infants 
receiving more than 50 % enteral feedings, but not full enteral feedings. This significant 
difference was due to a higher energy intake of PN and the difference lost the significance 
when more than 75 % of the total fluids were provided as enteral feedings.  
C
A 
B
A 
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Growth improved significanly during later years compared to year-group 2004-2005. At 
postnatal days 7 and 56 , the weight growth difference (∆WSDS) was 0.3 SDS (95 % CI: 0.1-
0.5, p<0.001) and 0.4 SDS (95 % CI: 0.2-0.7, p<0.001), respectively. 
In paper II, higher energy- and protein intake during the first week of life reduced initial 
growth restriction. Every additional energy intake of 10 kcal/kg/d during days 4-6 was 
associated with 0.08 higher weight SDS (WSDS) on day 7 (p<0.001), adjusted for GA, 
BWSDS, transfusions and days of MV. A higher PE ratio on days 4-6 was also significantly 
associated with initial weight development. Even though higher intakes of energy and protein 
on days 0-3 also were positively associated with ∆WSDS to day 7.  
The PE ratio increased over time during the early neonatal period (days 0-6) from 2.6 g 
protein/100 kcal in the Stockholm section of The EXPRESS cohort (2004-2007) to 3.5 g 
protein/100 kcal in the Stockholm research study (2008-2011) (p<0.001), Figure 13 A. 
During the late neonatal period (days 7-27) the difference in PE ratios between the two 
cohorts was 0.1 g protein/100 kcal.  
The PE ratio during days 0-6 increased over time from 2.6 g protein/100 kcal in year-groups 
2004-2005 and 2006-2007 to 3.3 g protein/100 kcal in year-group 2008-2009 and to 3.8 g 
protein/100 kcal in year-group 2010-2011 (p<0.001), Figure 13 B. The PE ratio during days 
7-27 decreased from 2.9 g protein/100 kcal in year-groups 2004-2005 and 2006-2007 to 2.8 
g/100 kcal in year-group 2008-2009. In year-group 2010-2011, the PE ratio increased with 
0.3 g protein/100 kcal compared to year-group 2008-2009 (p=0.001), Figure 13 B. 
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Figure 13. PE ratios (g protein/100 kcal) with the exclusion of blood products during early 
(0-6 days) and late neonatal (7-27 days) period, stratified by cohorts (A) and by year-groups 
(B).  
 
4.2.2 Paper II, nutrition and morbidity  
Mean protein intake excluding the blood products for the whole cohort was 1.8 g/kg/d on 
days 0-3, 2.9 g/kg/d on days 4-6 and 3.1 g/kg/d on days 7-27. With the inclusion of the blood 
products, protein intake increased by 1.1 g/kg/d, 0.5 g/kg/d and 0.3 g/kg/d, respectively for 
days 0-3, 4-6 and 7-27, respectively, compared to protein intake without blood products. 
When blood products were included, PE ratios were 4.6 protein g/100 kcal, 3.8 g protein/100 
kcal and 3.1 g protein/100 kcal, respectively for days 0-3, 4-6 and days 7-27. 
Association between 10 kcal/kg/d higher energy intake on postnatal days 7-27 and lower risk 
of BPD (9 %), adjusted for GA, BWSDS, antenatal corticosteroids, transfusions and 
mechanical ventilation (MV) was significant (p=0.029).  In infants with <10 days of MV, 
higher energy intake on days 7-27 was associated with reduced risk of BPD (p=0.011), in 
analyses adjusted for GA, BWSDS, antenatal corticosteroids, transfusions and MV. The 
association between energy intake and BPD was not significant in infants with >10 days of 
MV. Although higher intakes of both energy and protein on postnatal days 7-27 in infants 
with >10 days on MV, reduced the risk of BPD. Increased PE ratio at a mean energy intake of 
100 kcal/kg/d on days 7-27 was not associated with a significant reduction of BPD risk. 
However, every 0.5 g/kg/d increase in protein intake when energy intake equals 120 
kcal/kg/d reduced the risk of BPD by 25 % (p=0.034).  
Association between 10 kcal/kg/d higher energy intake on postnatal days 7-27 and lower risk 
of ROP of any stage (6 %), adjusted for GA, BWSDS, transfusions and MV was significant 
(p=0.005). No significant association was demonstrated between 10 kcal/kg/d increase on 
postnatal days 7-27 and lower risk of severe ROP. In infants with <10 days of MV, higher 
B 
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energy intake on days 7-27 was associated with reduced risk of ROP (p=0.003) in adjusted 
analyses. When energy intake increased from 110 to 120 and 120 to 130 kcal/kg/d, the 
estimated absolute risk of ROP decreased with 10 % and 8 %, respectively. In addition, when 
the analyses were adjusted for year-groups, associations in infants with <10 days MV were 
significant (RR 0.89, 95 % CI 0.81-0.98; p=0.024), while this was not the case in infants with 
>10 days MV (RR 1.01, 95 % CI 0.97-1.04; p=0.768). The PE ratio on days 7-27 was not 
associated with risk of ROP in the adjusted analyses. 
 
4.2.3 Paper III, perioperative nutrition 
Perioperative nutrition was suboptimal according to minimal estimated nutritional needs (110 
kcal/kg/d, 4 g protein/kg/d, 4.8 g fat/kg/d and 12 g carbohydrate/100 kcal) and energy, 
protein, fat and fluid intakes on the third day post-surgery for PDA were still not improved 
compared to intakes three days prior ductal ligation.  
Energy intake on the day of surgery (day 0) did not differ significantly between infants who 
underwent ductal ligation for PDA during the first 6 postnatal days (early neonatal period), 
postnatal days 7-27 (late neonatal period) or >28 postnatal days (postneonatal period), Figure 
14 A. In contrast, energy intake during perioperative week improved for every following 
neonatal period (74 kcal/kg/d, 93 kcal/kg/d, 103 kcal/kg/d, p=0.001), Figure 14 B. Protein 
intake during day 0 was highest in infants who underwent ductal ligation during the first 6 
postnatal days (early neonatal period) and thereafter decreasing for every following neonatal 
period (3.7 g protein/kg/d, 2.7 g protein/kg/d, 2.1 g protein/kg/d, p=0.003), Figure 14 C. 
Protein intake during perioperative week was equal in infants who underwent ductal ligation 
during the early and late neonatal periods (3 g/kg/d) and lower compared to those who 
underwent ductal ligation during the postneonatal period. The difference in protein intake 
between infants who underwent ductal ligation during the early/late neonatal periods and the 
postneonatal period was 0.3 g/kg/d (p=0.02), Figure 14 D.  
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Figure 14. Data are median energy (kcal/kg/d) intakes during day of surgery = day 0 (A) and 
perioperative week starting 3 days prior to PDA ligation and ending after 3 days post-surgery 
(B), as well as protein (g/kg/d) intakes during day of ductal ligation = day 0 (C) and 
perioperative week starting 3 days prior ductal ligation for PDA and ending 3 days post 
ductal ligation (D), stratified by neonatal period. Early (days 0-6) and late (days 7-27) 
neonatal periods as well as postneonatal (>28 days) period denote the postnatal age in which 
ductal ligation took place. Energy- and protein intakes include nutritional content of blood 
products. 
D 
C 
B 
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4.2.4 Paper IV, perioperative nutrition, stratified by NICU 
Differences between NICUs regarding nutritional intakes were observed and regarding total- 
and enteral fluid intakes as well as concentration of parenteral nutrition, differences were 
large. Furthermore, discrepancy between recommended concentration of ready-to-use 
solutions of parenteral nutrition (205) and the NICU supplying PN with the highest 
concentration, compared to other NICUs, was 42 % and 39 % regarding parenteral energy 
and protein concentration, respectively. Figure 15 shows an EPT infant who needs 
professional care.  
 
 
© NICU Karolinska University Hospital 
Figure 15. Extremely preterm infant in an incubator. 
 
 36 
5 DISCUSSION  
5.1 GENERAL DISCUSSION 
The overall objective of this thesis was to study energy, macronutrient and fluid intakes of 
EPT infants treated in NICUs in Sweden during an 8-year period from 2004 to 2011. The 
general research questions were: i) to describe nutritional intakes over time in Stockholm 
and the impact on growth and morbidities such as BPD and ROP (paper I and II), and ii) to 
describe perioperative nutrition in EPT infants who underwent surgical treatment of PDA 
and investigate differences between Swedish NICUs regarding nutrition during the week 
surrounding PDA surgery.   
The main findings of this thesis demonstrate suboptimal energy and macronutrient intakes 
in EPT infants in Sweden during the study period from 2004 to 2007. However, energy and 
macronutrient intakes increased in Stockholm over the period from 2004 to 2011, mean 
protein intake during postnatal days 7 to 27 did not meet minimal estimated nutritional 
needs at full enteral nutrition according to Swedish guidelines (20). Higher energy intake on 
postnatal days 7 to 27 was associated with a lower risk of BPD and ROP and an association 
was seen between higher protein intake and reduced risk of BPD when sufficient energy was 
provided. The findings also showed that energy intake in combination with protein intake had 
a positive impact on weight development during the first postnatal week.  
Suboptimal perioperative supply of energy and macronutrients was demonstrated in EPT 
infants undergoing ductal ligation for PDA in Sweden, particularly on the day of surgery. 
Moreover, problem with suboptimal perioperative nutrition did not improve with GA and 
largest deficits were faced by infants that underwent ductal ligation during early neonatal 
period (days 0-6). Nutritional intakes differed between Swedish NICUs but particularly 
regarding fluid intake, the difference between NICUs was large. Distribution between enteral- 
and parenteral fluid intakes differed also highly between NICUs as well as parenteral energy- 
and protein concentrations.    
 
5.2 ENERGY AND MACRONUTRIENT INTAKE   
During the first postnatal week, energy and protein intake improved over the 8-year period 
(206) but did not meet the minimal estimated nutritional needs for day 4, according to 
Swedish guidelines (20). In contrast, fat intake met these minimal needs already during the 
years 2008-2009, coinciding with higher enteral intakes. Figure 16 shows detailed 
information regarding an individualised PN composition.  
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© Karolinska University Hospital 
Figure 16. Protein, carbohydrates and micronutrient content in individual composition of 
parenteral nutrition.  
 
Protein accretion is occurring when energy supply is at least 120 kcal/kg/d (79, 80), 
however, the ideal PE ratio is not known (65). In our study, paper II, PE ratios (including 
blood products) of 4.6 protein g/100 kcal and 3.8 g protein/100 kcal on days 0 to 3 and 4 to 6, 
respectively (207), were higher when compared to different PE ratios suggested in recent 
literature ranging from 3.1 to 4.1 g protein per 100 kcal (18, 81). PE ratio on days 4 to 6 was 
significantly associated with initial weight development and there was an association between 
higher energy and protein intake and reduced risk for BPD, particularly during the later 
period (2008-2011) when higher energy and protein intakes were supplied (207). 
Inappropriate energy and protein intakes reduce growth, however, higher energy intake may 
enhance the rate of increase in skinfold thickness, if protein intake is appropriate (208). The 
PE ratio in the diet impacts the ratio of lean body mass to fat mass in the gained weight. 
Fairly et al showed that higher PE ratio (3.2 g/100 kcal versus 2.6 g/100 kcal) did not 
influence the proportion of fat to lean tissue in gained weight (209). In a small RCT study, 
growth and body composition of VLBW infants were investigated by comparing different PE 
ratios (210). Infants in the two experimental groups received high energy and high protein 
diets with different PE ratios: 150 kcal/kg/d with 4.2 g protein/kg/d, corresponding to PE 
ratio of 2.8 g/100 kcal and 150 kcal/kg/d with 4.7 g protein/kg/d, corresponding to PE ratio of 
3.1 g/100 kcal. Energy and protein intake corresponding to PE ratio of 2.8 g protein/100 kcal 
was sufficient to increase weight growth and accretion of lean body mass.  
Longer duration of MV during the later time period (2008-2011) was occurring among a 
higher proportion of infants developing BPD. Regarding higher energy intake on postnatal 
days 4 to 6 and BPD or ROP, there was no statistical significant association, although our 
results were towards an association between higher energy intake on postnatal days 4 to 6 and 
lower risk of severe ROP. It is possible to make comparisons between different stages of 
ROP since the diagnosis is based on visualized differences in retinal vascularisation. The 
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diagnosis of BPD might not be a valid predictor of later pulmonary problems because of its 
less distinct character. Severe ROP, NEC, and severe intraventricular haemorrhage (although 
not BPD) were associated with postnatal growth restriction according to Griffin et al (211).  
Perioperative nutrition is suboptimal and infants that underwent ductal ligation during early 
neonatal (0-6 days) period faced the lowest nutritional intakes (212). Noteworthy is that 
protein intake during day of ductal ligation and perioperative week was highest in infants 
ligated during early neonatal period and lowest in those ligated during post neonatal (>28 
days) period, respectively. Accordingly, PE ratio including blood products decreased from 
3.9 g protein/100 kcal to 2.7 g protein/100 kcal. Recent studies demonstrated associations 
between PDA surgery, white matter injury and brain damage, however, data on nutritional 
intakes were not reported (213, 214). Since significance of undernourishment for outcome in 
EPT infants undergoing ductal ligation is still unknown, further investigation is required. 
Moreover, optimal postnatal age for surgical ligation of PDA is still not known (152, 153) 
and now there is a trend towards mainly pharmacological treatment of PDA.   
Perioperative nutrition differed largely between NICUs in Sweden, paper IV. NICU A had 
highest energy and fat intake as well as the highest proportion of enteral feeds, compared to 
all other NICUs. However, NICU A’s energy intake did not meet minimal estimated 
nutritional needs of full EN, according Swedish guidelines (20). 
 
5.3 FLUID INTAKE  
The proposed cause of a physiological initial weight loss after birth is reduction of 
extracellular fluid. A reduction of 0.8 SDS in weight to postnatal day 7 followed by growth 
parallel to the Fenton growth chart in healthy preterm infants was suggested by Rochow et 
al (112). During the first postnatal week, intake of energy and protein rather than fluid 
intake was important for weight development, paper II (207). This result shows that 
attentive nutritional care has the potential to reduce initial growth restriction.  
A Cochrane review based on five randomised clinical trials assessed that a careful restriction 
of fluid intake, not allowing for dehydration could be expected to decrease the risks of BPD, 
PDA, NEC, intracranial haemorrhage and death (156). In this review, fluid intakes during 
early (0-6 days) and late (7-27 days) neonatal period, between 60 to 80 ml/kg/d and 122 to 
150 ml/kg/d, respectively, were considered as restricted, while fluid intakes during early and 
late neonatal period, between 140 to 150 ml/kg/d and 169 to 200 ml/kg/d, respectively, were 
considered as liberal. In our Stockholm studies (206, 207), fluid intake during early neonatal 
period could neither be accounted as restricted nor as liberal. In contrast, in the national 
studies, fluid intakes in three of five NICUs could be considered as liberal ranging from 123 
ml/kg/d to 132 ml/kg/d. During late neonatal period, fluid intakes during 2-year period of 
2004-2005 could be considered as restricted (147 ml/kg/d), while fluid intakes during all 
other years neither were restricted nor liberal. In contrast, our national studies showed liberal 
  39 
fluid intake in EPT infants who underwent ductal ligation during early neonatal period (212). 
Large difference was demonstrated between NICUs regarding fluid intakes and during late 
neonatal period, fluid intakes ranged from restricted at NICU B (123 ml/kg/d) to liberal at 
NICU E (187 ml/kg/d), paper IV.   
Suboptimal nutrient concentration in PN requires increased fluid amounts to meet estimated 
nutritional needs. During the years 2004 and 2007 parenteral energy concentration ranged 
from less than 40 kcal/100 ml to approximately 60 kcal/100 ml, while parenteral protein 
concentration ranged from less than 1 g protein/100 ml to approximately 2 g protein/100 ml, 
paper IV. In 2009, a standardised, extemporaneously prepared parenteral nutrition “Start-
up” was introduced to facilitate the early start of protein supply on nights, weekends, or 
holidays when individually prescribed parenteral nutrition could not be prepared (206). 
Concentration of “Start-up” is 2.7 g protein/100 ml and only 50 kcal/100 ml, since fat is not 
included in this parenteral solution. Aforementioned PN concentrations did not meet the 
recommended content in modern all-in-one-bags, containing 91 kcal/100 ml and 3.1 g 
protein/100 ml (205). The use of highly concentrated PN makes it easier to meet estimated 
nutritional needs without exceeding fluid prescriptions, despite the need of extra fluid supply 
because of medical infusions.  
 
5.4 ACTION BUNDLES OF NUTRITIONAL CHANGES 
However, changes in nutritional management during the 8-year study period certainly 
occurred at all Swedish NICUs, they were studied in detail at NICUs in Stockholm, paper I 
(206). These changes regarded e.g., implementation of guidelines and update of local 
guidelines, introduction and implementation of computer software, introduction of new 
nutritional products and nutritional education of the ward staff.  
 
5.4.1 Guidelines 
International guidelines regarding PN and EN (17-19, 197) were available during the 8-year 
study period (2004-2011) and in Stockholm local PN and EN guidelines were based on 
these guidelines. Adherence to the international guidelines could occur before publication 
and update of local guidelines, which e.g., was the case in 2010 when aggressive feeding 
advancement strategy including earlier introduction and faster advancement of HMF was 
implemented, paper I (206). Clinical practice varied between Swedish NICUs, which already 
was noted during data acquisition regarding Nutrium-EXPRESS study (99, 215) and later on 
demonstrated in Paper IV.  
Most guidelines are for healthy, growing preterm infants weighing >1000 grams as they are 
based on older studies performed of infants with birth weights between 1500 and 2000 
grams (216, 217). However, in 2014, The National Board of Health and Welfare published 
 40 
Swedish national guidelines (20), based on previous international guidelines but also on 
results of recent studies performed on EPT infants (99, 212). To meet the recommendation 
of postnatal day four including 50 % EN of the total fluid intake, according to Swedish 
guidelines constitutes a challenge for the ward staff. Differences between recent nutritional 
guidelines (20, 64, 65) and those from the last decades (17-19, 184, 194) are small, 
regarding e.g., energy- and macronutrient intakes, however, Tsang et al (17) recommended 
enteral energy intake of 150 kcal/kg/d with chronic lung diseases considering higher energy 
expenses. Recent parenteral nutritional guidelines regarding critically ill children at the 
paediatric intensive care unit recommend considering withholding macronutrients in PN for 
one week, while supplying micronutrients (65).  
Studies have demonstrated improved nutritional intake and better postnatal growth in 
preterm infants, when enhanced nutrition protocols were implemented (218, 219). Despite 
achieving energy and protein intakes close to the target levels according guidelines, Saenz 
de Pipaon et al demonstrated difficulties in meeting intrauterine growth rates (121). 
Improved growth over subsequent years compared to the period, between 2004 and 2005 
was demonstrated in our study, paper I (206), but infants still did not reach the intrauterine 
growth curve.  
 
5.4.2 Lack of guidelines 
Even though progress has been made during the last decades regarding neonatal nutritional 
needs, suboptimal nutrition is frequently occurring at NICUs, despite the knowledge that 
undernourishment contributes to mortality, morbidity and poorer developmental outcome 
(186, 220).  
To our knowledge, nutritional guidelines for specific neonatal morbidities or treatments 
such as e.g., ductal ligation are lacking in literature. Suboptimal perioperative nutrition did 
not improve with GA, which could indicate that the underlying causes may reflect practices 
or guidelines, and not constraints related to GA, paper III (212). Enteral intolerance or 
limited vascular access in the most immature infants are some of the constraints related to 
GA. Moreover, optimal perioperative feeding strategies regarding term born infants with 
congenial heart disease are unknown, which may cause large variations in perioperative 
feeding practise between different hospitals (221). 
Lack of guidelines regarding feeding intolerance and the ward staff’s anxiety over infants 
developing NEC may lead to suboptimal nutritional intakes. Consensus regarding feeding 
intolerance parameters such as gastric residuals of prior feeding, bile or blood stained 
residuals, emesis, abdominal distention/tenderness and change in stool pattern/consistency 
has to be reached to prevent unnecessary withholding of feeds affecting nutritional intakes. 
In study context, reliable results are largely depending of careful defined criteria for feeding 
intolerance and its adherent application (170). At the NICU, optimal infrastructure and 
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designated ward staff are warrant for improved adherence to nutritional guidelines (220).  
Furthermore, achieving adequate nutritional intake constitutes a challenge during the 
transition phase from parenteral to enteral nutrition. Important reasons for difficulties in 
reaching target intakes could be, as before mentioned, lack of consensus on indications for 
withholding feeds and timing of the introduction of HMF. Faster advancement of daily 
increments (>24 ml/kg/d) together with use of HMBFs might prevent the energy slope 
during the transition phase from PN to EN (169). 
 
5.4.3 Changes in clinical practice      
Facilitating software, enhanced focus and education of personnel during the 8-year period 
had a combined impact leading to increased nutritional intake in EPT infants at the 
Stockholm NICUs. Although the tradition of performing nutritional calculations on an 
individual basis according to analysed HM was present before in Stockholm, the entry of 
Nutrium facilitated nutritional processes as well as engagement and education of the ward 
staff in nutritional issues. Wackernagel et al demonstrated the effect of computer software to 
facilitate prescriptions and documentation of nutritional intake in preterm infants (222). A 
supplemental computerised ICU system (Centricity Critical Care Clinisoft, GE Healthcare), 
registering all PN and medications as well as EN including fortification of MOM and 
DHM, facilitated the supervision of the nutritional process at NICUs in Stockholm (206). 
Documentation in the ICU system on a daily basis of fortified MOM and or 
DHM/premature formula prepared in the ward kitchen was performed by nutrition 
assistants, Figure 17.  
 
 
© Vera Westin 
Figure 17. Dietitian assistant in the ward kitchen documenting individually fortified breast 
milk in the computerised ICU system. 
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In a recent study, Rochow et al observed that growth and nutrition comprised a greater part 
in the daily medical discussion after the introduction of an electronic pre-structured 
prescription ordering system giving day-by-day instructions for nutrition on an individual 
basis (108).  
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6 CONCLUSIONS 
 Updated guidelines and their adherent application together with introduction and 
implementation of computer software, introduction of new nutritional products, 
intensification of nutritional education of ward staff contributed to improved 
nutritional intakes for EPT infants cared for in Stockholm. 
 
 Energy and protein intakes during the first four postnatal weeks increased in EPT 
infants in Stockholm during the 8-year period.   
 
 Improved energy and protein intakes during the first postnatal week were associated 
with reduced initial growth restriction. 
  
 Improved nutritional intakes were associated with reduced occurrence of BPD and 
ROP.  
 
 Perioperative nutrition in EPT infants undergoing ductal ligation was suboptimal 
compared to estimated nutritional requirements in Sweden. 
 
 Total fluid, parenteral and enteral intakes differed largely between Swedish NICUs 
as well as the concentration in PN. 
 
 The overall results from this thesis conclude that there are associations between 
higher nutritional intakes and increased growth and decreased risk for morbidity. 
Furthermore, nutritional intakes during perioperative week do not meet estimated 
nutritional requirements and differ between NICUs. There is room for improvement 
regarding nutritional intakes for EPT infants in general and during the week 
surrounding ductal ligation in particular.  
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7 FUTURE PERSPECTIVES 
 Despite our knowledge, we still do not know the optimal preconditions regarding 
nutrition and growth nor what optimal nutrition and growth should look like and 
more research is needed in these vulnerable infants. 
 Closer collaboration between dietitians, nutrition assistants, nurses, neonatologists, 
speech therapists and when surgical treatments are involved, anaesthesiologists and 
paediatric surgeons is necessary to increase awareness of the risk of undernutrition 
in EPT infants and further improve nutrition in the ward.  
 Improvements of heat treatment and optimisation of HM fortification, regarding 
milk processing in HMB, should be focus of research. Furthermore, the potential 
clinical benefits of processed and fortified DHM need to be investigated.   
 Increased resources are required to meet the follow-up needs of the vulnerable infant 
and their families, since many of infants born at the lower limit of viability are 
affected of undernutrition and neurodevelopmental disability. 
 The target of the research should be that more EPT infants face a healthy future. 
Figure 18 shows healthy twins on return visit at the NICU. 
 
   
© Ulrika Eriksson 
Figure 18. Twins born in gestational week 25 and three days. On the photograph, 
they are five months corrected age.  
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8 SVENSK SAMMANFATTNING 
Normalt varar en graviditet ungefär 40 veckor. I Nordeuropa är antalet barn som föds 
prematurt, d v s före 37 graviditetsveckor, lägre än i andra regioner eller länder. Prematur 
födsel kan indelas i tre kategorier: Måttligt prematur födsel (32 till <37 graviditetsveckor), 
mycket prematur födsel (28 till <32 graviditetsveckor) och extremt prematur födsel (<28 
graviditetsveckor). Av cirka 100 000 barn som föds varje år i Sverige är ungefär 1 % födda 
före graviditetsvecka 32. I den nationella kohorten ”The Extremely Preterm infants in 
Sweden study” (EXPRESS), visades ett födelsetal på 0,2 % avseende barn födda före 
graviditetsvecka 27 under åren 2004 och 2007.  
Dödligheten och sjukligheten är fortfarande hög bland extremt prematurfödda barn men har 
förbättrats stort under de senaste årtiondena. Under åren 1990 och 1992 överlevde inga barn 
som föddes i graviditetsvecka 22 enligt en svensk studie som publicerades 1997. Bara tio år 
senare visades i EXPRESS att 10 % (n=5) av barn som föddes i graviditetsvecka 22 
överlevde till ett-års ålder. Under 1960/70- talen introducerades nutritionsbehandlingen först 
två till tre dygn efter födelsen om det prematurfödda barnet fortfarande visade livstecken. En 
behandlingsform som ter sig oetisk idag. För att förebygga att nutritionsbrister som kan 
finnas vid födelsen förvärras ytterligare, förespråkar nuvarande nutritionsriktlinjer insättning 
av nutritionsbehandling så snabbt som möjligt, redan inom några timmar efter födelse.  
Tre sjukdomar som ofta drabbar extremt prematurfödda barn är bronkopulmonell dysplasi 
(BPD), prematuritetsretinopati (ROP) och öppetstående ductus arteriosus (PDA). Såväl 
lungsjukdomen BPD som ögonsjukdomen ROP beror på störd utveckling av lungorna, 
respektive ögats näthinna och är mycket vanligt förekommande hos extremt prematur födda 
barn. BPD kan orsaka lungsjukdom även senare i livet och den allvarligaste formen av ROP 
kan leda till blindhet. Sambandet mellan näringsintag och risk för BPD respektive ROP har 
påvisats i ett fåtal observationsstudier. Ungefär 50 till 80 % av extremt prematurfödda barn 
drabbas av BPD eller ROP. Ett blodkärl som kallas ductus arteriosus förbinder lungartären 
med stora kroppspulsådern (aorta) under fostertiden. Med hjälp av prostaglandiner hålls 
kärlet under fostertiden öppet eftersom cirkulation genom lungorna inte behövs. Vanligen 
slutar sig blodkärlet snabbt efter födelsen, redan efter första dygnet men hos prematura barn, i 
synnerhet de som föds inom de lägsta graviditetsveckorna är stängningen ofta fördröjd. 
Obehandlad PDA kan medföra förhöjd andnings- och hjärtfrekvens, matintolerans och 
försämrad lungfunktion. I Sverige behandlas ungefär 60 % av de extremt prematurfödda 
barnen för PDA.   
Syftet med denna avhandling är att studera det extremt prematurfödda barnets nutritionsintag 
avseende energi, makronutrienter (protein, fett, kolhydrater) och vätska: i) över tid och 
intagets samband med tillväxt, BPD samt ROP och ii) under operationsveckan i samband 
med kirurgibehandling av PDA.    
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Samtliga studier inom denna avhandling är epidemiologiska och baserade på prospektivt 
insamlade bakgrundsuppgifter från EXPRESS kohorten om t ex neonatal sjuklighet, 
dödlighet, behandlingsinsatser och nutritions- och tillväxtuppgifter från sjukhusets 
patientjournaler och kvalitetsregister. Detaljerade nutritions- och tillväxtuppgifter 
registrerades retrospektivt i ett datorprogram för nutrition och tillväxt, Nutrium. Insamlingen 
och registreringen av nutritions- och tillväxtuppgifter har pågått under flera år och omfattar 
information om såväl parenteral som enteral nutrition, egen- och donerad bröstmjölk, enterala 
berikningsprodukter, samt vitamin och mineralpreparat. Mycket hög andel av egen 
bröstmjölk och all donator mjölk är analyserad på innehåll av makronutrienter (protein, fett, 
kolhydrater). Analys av bröstmjölk är en förutsättning om berikning på individuell basis ska 
kunna tillämpas. Dessutom inkluderades läkemedel spädda i glukos eller saltlösning, 
spolvätskor samt givna blodprodukter i datainsamlingen.   
I studie I studerades hur nutritionsrelaterade ändringar över en åtta årsperiod (2004- 2011), 
påverkade nutritionsintag och tillväxt av extremt prematurfödda barn i Stockholm. 
Uppdaterade internationella och lokala nutritionsriktlinjer, introduktion av Start-up (en 
standard parenteral nutritionspåse), introduktion av Nutrium och Clinisoft (avancerat, web-
baserat journalsystem), utökad anställning av dietist och utökad undervisningsfrekvens av 
avdelningspersonal (inte minst nutritionsassistenter), är några av ändringarna som vidtogs och 
implementerades under studieperiodens åtta år. Studieresultat visade förbättrat nutritionsintag 
och tillväxt hos barnen, i synnerhet under den senare halvan av perioden (2008-2011). Trots 
detta var det många barn i slutet av studieperioden som fortfarande inte mötte minimala 
uppskattade nutritionsbehov.  
Studie II är baserad på samma kohort som studie I, men med fokus på energi- och 
proteinintag under den första veckan och månaden och dess påverkan på tillväxten och risken 
för BPD och ROP. Resultaten visade att högre energi- och proteinintag under den första 
levnadsveckan var förknippat med förbättrad viktutveckling. Under åren 2008 till 2011 var 
ökat intag av energi och protein under levnadsdag 7 till 27 förknippat med en minskad risk 
för BPD, vilket inte sågs för barn födda före 2008. Hos barn med färre än tio dagar i 
respiratorvård var ökat energiintag under levnadsdag 7 till 27 associerat med en minskad risk 
för ROP, vilket inte gällde för barn som hade fler än tio respiratordagar. 
I studie III undersöktes nutritionen under operationsveckan som påbörjades tre dagar innan 
och slutade tre dagar efter kirurgisk behandling av PDA i Sverige under åren 2004 till 2007. 
Resultaten visade att intaget av energi och makronutrienter under den operationsveckan var 
lägre än uppskattat behov. Sämst var näringsintaget under operationsdagen (dag 0) samt hos 
barn som opererades under den första levnadsveckan. Näringsintaget förbättrades mot slutet 
av veckan men fortfarande på dag tre efter operation var intaget av energi, protein och fett 
lägre jämfört med dag tre innan operation. Det låga näringsintaget var oberoende av barnets 
graviditetsålder. 
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Studie IV är baserad på samma kohort som studie III, men med fokus på skillnader mellan de 
neonatala intensivvårdsavdelningarna i Sverige avseende barnens intag av energi, 
makronutrienter och vätska under operationsveckan. Nutritionsintaget skiljde sig mellan 
avdelningarna; i synnerhet avseende vätskeintag och det enterala- och parenterala 
nutritionsintaget, var skillnaderna stora. Avseende den parenterala nutritionens koncentration 
var skillnaderna mellan neonatalavdelningarna också stora men inga koncentrationsresultat 
nådde upp till det rekommenderade koncentrationsmålet för parenteral nutrition. Inga av 
inkluderade avdelningarna hade tillgång till sjukdomsspecifika nutritionsriktlinjer. 
Sammanfattningsvis visar denna avhandling att det finns samband mellan nutrition, tillväxt 
och minskad risk för sjuklighet. Trots förbättrat nutritionsintag över tid finns det fortfarande 
potential för ytterligare optimering av nutritionsbehandling på Stockholms neonatala 
intensivvårdsavdelningar. Avsaknad av sjukdomsspecifika riktlinjer öppnar för variation 
mellan de svenska neonatala intensivvårdsavdelningarna, avseende nutrition under 
operationsveckan. Behov av konsensus beträffande nutritionsbehandling under 
operationsveckan föreligger. Fortsatt forskning inom neonatal nutrition behövs, inte minst 
med tanke på att det fortfarande är oklart hur optimal nutrition och tillväxt ska se ut för de 
allra minsta barnen inom sjukvården.  
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